Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | MK8033 |
Synonyms | |
Therapy Description |
MK8033 is an inhibitor of MET and MST1R (RON) that suppresses mTOR signaling, potentially resulting in reduced survival and colony formation, increased apoptosis, and inhibition of tumor growth (PMID: 23792360, PMID: 33163272). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MK8033 | MK-8033|HQP8361|HQP 8361|HQP-8361|MK 8033 | MET Inhibitor 59 RON Inhibitor 11 | MK8033 is an inhibitor of MET and MST1R (RON) that suppresses mTOR signaling, potentially resulting in reduced survival and colony formation, increased apoptosis, and inhibition of tumor growth (PMID: 23792360, PMID: 33163272). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|